U.S. markets closed

HC2 Holdings, Inc. (HCHC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
3.5100-0.0700 (-1.96%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close3.5800
Open3.5900
Bid3.5100 x 800
Ask3.5900 x 900
Day's Range3.4700 - 3.6000
52 Week Range2.0600 - 4.7500
Volume187,586
Avg. Volume399,646
Market Cap272.418M
Beta (5Y Monthly)2.31
PE Ratio (TTM)N/A
EPS (TTM)-0.0020
Earnings DateAug 09, 2021 - Aug 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateAug 28, 2013
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • HC2 Holdings Provides $15 Million Series C Investment to Portfolio Company R2 Technologies
    GlobeNewswire

    HC2 Holdings Provides $15 Million Series C Investment to Portfolio Company R2 Technologies

    Investment to Expand Corporate Footprint and Accelerate Glacial Rx™ CommercializationNEW YORK, July 21, 2021 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2” or “the Company”) (NYSE: HCHC) today announced that it has provided an additional $15 million in Series C funding to R2 Technologies Inc. ("R2") at a post-money valuation of $150 million. The investment was made through HC2’s life sciences subsidiary Pansend Life Sciences (“Pansend”), a founding investor in R2. The funds will be used to expand

  • HC2 Holdings, Inc. Announces New Name, INNOVATE Corp.
    GlobeNewswire

    HC2 Holdings, Inc. Announces New Name, INNOVATE Corp.

    Name Change to INNOVATE Corp. Expected in Q3 2021 Focused on Infrastructure, Life Sciences and Spectrum NEW YORK, July 09, 2021 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (NYSE: HCHC) today announced that it will change its name to INNOVATE Corp. The name change is expected to become effective by the end of the third quarter of 2021. “The name INNOVATE perfectly describes our corporate ethos – INNOVATE is who we are and INNOVATE is what we do,” said Avie Glazer, Chairman of HC2. “INNOVATE is best-in

  • HC2 Holdings (HCHC) Completes Insurance Segment Divestment
    Zacks

    HC2 Holdings (HCHC) Completes Insurance Segment Divestment

    The divestment of the Insurance segment fetches HC2 Holdings (HCHC) $65 million in cash, which is part of the total consideration. It will help the company focus on other key businesses.